News

  • Drug improves survival in triple-negative breast cancer

    A targeted therapy has improved survival compared with chemotherapy in patients with triple-negative breast cancer who cannot receive immunotherapy. The drug, an antibody-drug conjugate (a treatment that delivers chemotherapy directly to cancer cells), slowed tumour progression and extended survival compared with standard chemotherapy in triple-negative breast cancer – an aggressive form lacking three common receptors [...]

  • Scientists turn human skin cells into eggs in IVF breakthrough

    Researchers have created human eggs from skin cells, in a breakthrough that could transform IVF treatment for couples who have no other options. The work remains at an early stage, but if scientists can refine the process it could allow women who are infertile due to age, illness or medical treatment to have genetically related [...]

  • Mothers’, not fathers’, mental health directly linked to their children’s, study shows

    Mothers’ feelings of being overwhelmed and unhappiness, not fathers’, are directly associated with their children’s feelings of nervousness, worry and unhappiness, new research has revealed. The study definitively confirms the mother’s role as central to the emotional wellbeing of the family unit. Though other researchers have focused on isolated relationships between mother and child, this [...]

  • Daily pill could delay menopause ‘by years,’ study finds

    Women who regularly take fish oil supplements could reduce their risk of early menopause by up to 95 per cent, new research suggests. The study, which looked at data from more than 3,500 British women, found that those who took fish oil supplements were far less likely to experience early menopause than those who did [...]

  • FDA plans to revise black box warning on menopause hormone therapies

    The US Food and Drug Administration (FDA) plans to update the black box warning on menopause hormone therapies soon, commissioner Dr Martin Makary has said. The move follows years of debate over safety alerts that have limited access to treatment for millions of women with menopause symptoms. "We are in serious discussions now about what [...]

  • At-home abortions safe and effective up to 12 weeks, study finds

    At-home abortions should be permitted for up to 12 weeks across the UK, researchers say, after finding they are as safe as procedures carried out in hospital. The study reviewed outcomes of abortions between 10 and 12 weeks of pregnancy in NHS Lothian, Scotland, from 2020 to 2025. Medical abortion involves taking two drugs – [...]

  • NHS introduces new ovarian cancer screening for high-risk women

    High-risk women can now delay ovary removal surgery through NHS screening, helping them preserve fertility and avoid early surgical menopause. The ROCA test tracks women with BRCA gene mutations every four months, monitoring cancer risk markers instead of requiring immediate preventive surgery. University College London Hospitals NHS Foundation Trust has begun rolling out the programme, [...]

  • New report exposes perimenopause as biggest blind spot in women’s health

    Women’s wellness company NNABI has released the first nationally representative research dedicated entirely to perimenopause. The decade-plus hormonal life stage begins as early as mid-30s and is often dismissed, misdiagnosed or ignored.  The Peri Power Report uncovers a staggering awareness gap. Although the US women surveyed were experiencing an average of seven perimenopause-related symptoms — [...]

  • Transform launches Transform Femme

    Transform, the UK’s leading clinic for orthopaedic, cosmetic and elective surgery, today announces the launch of Transform Femme, a pioneering new service providing first-class treatment for a wide range of gynaecological concerns. Launching in October 2025, Transform Femme will be available at Transform’s state-of-the-art Electiva Hospitals in Manchester, Glasgow, Newcastle and London as well as through specialist [...]

  • Femtech describes a category. Women’s health describes a life

    By Ema founder and CEO, Amanda Ducach Ema’s claim to fame is that “she” was the first agentic AI for women’s health. That means that as the CEO, I get to spend my days speaking with women’s health founders and funders about AI for women.  And… I have noticed something that I wanted to share. [...]